Overview
Tozaro, a Bedford-based biotech company, has secured €6.9 million (£6 million) in funding led by Mercia Ventures. The funding will help Tozaro advance its smart polymer technology, which aims to reduce costs and improve access to life-saving cell and gene therapies. With this round, the company has raised a total of €27.2 million (£23.7 million) to date, focusing on enhancing the production of viral vectors for therapies that can be prohibitively expensive for patients.
Products
Loading...
Recent Deals
Investors: Mercia Ventures
Tozaro, a Bedford-based biotech company, has secured €6.9 million (£6 million) in funding led by Mercia Ventures. The funding will help Tozaro advance its smart polymer technology, which aims to reduce costs and improve access to life-saving cell and gene therapies. With this round, the company has raised a total of €27.2 million (£23.7 million) to date, focusing on enhancing the production of viral vectors for therapies that can be prohibitively expensive for patients.